Medicinal chemistry of tetrazoles
VA Ostrovskii, RE Trifonov, EA Popova - Russian Chemical Bulletin, 2012 - Springer
Abstract Properties of responsible for biological activity tetrazoles are considered. Examples
are given of active pharmaceutical ingredients of modern drugs containing the tetrazole ring …
are given of active pharmaceutical ingredients of modern drugs containing the tetrazole ring …
Nonclassical biological activities of quinolone derivatives
M Daneshtalab, A Ahmed - Journal of Pharmacy & …, 2012 - journals.library.ualberta.ca
Quinolones are considered as a big family of multi-faceted drugs; their chemical synthesis is
flexible and can be easily adapted to prepare new congeners with rationally devised …
flexible and can be easily adapted to prepare new congeners with rationally devised …
Scaffold‐hopping: how far can you jump?
G Schneider, P Schneider… - QSAR & Combinatorial …, 2006 - Wiley Online Library
Finding new isofunctional chemotypes with the aim of identifying new lead candidates
remains a challenging task in medicinal chemistry. Different virtual screening techniques …
remains a challenging task in medicinal chemistry. Different virtual screening techniques …
Inhibitors of influenza virus polymerase acidic (PA) endonuclease: contemporary developments and perspectives
H Ju, J Zhang, B Huang, D Kang, B Huang… - Journal of Medicinal …, 2017 - ACS Publications
Influenza virus (IFV) causes periodic global influenza pandemics, resulting in substantial
socioeconomic loss and burden on medical facilities. Yearly variation in the effectiveness of …
socioeconomic loss and burden on medical facilities. Yearly variation in the effectiveness of …
HIV‐1 integrase inhibitors: 2005–2006 update
Abstract HIV‐1 integrase (IN) catalyzes the integration of proviral DNA into the host genome,
an essential step for viral replication. Inhibition of IN catalytic activity provides an attractive …
an essential step for viral replication. Inhibition of IN catalytic activity provides an attractive …
Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase
K Ma, P Wang, W Fu, X Wan, L Zhou, Y Chu… - Bioorganic & medicinal …, 2011 - Elsevier
HIV-1 integrase is an essential enzyme for viral replication and a validated target for the
development of drugs against AIDS. With an aim to discover new potent inhibitors of HIV-1 …
development of drugs against AIDS. With an aim to discover new potent inhibitors of HIV-1 …
Effect of non-covalent interactions on the stability and structural properties of 2, 4-dioxo-4-phenylbutanoic complex: a computational analysis
M Mohammadi, F Sharifi… - Journal of Molecular …, 2024 - Springer
Abstract Context The 2, 4-dioxo-4-phenylbutanoic acid (DPBA) is a subject of interest in
pharmaceutical research, particularly in developing new drugs targeting viral and bacterial …
pharmaceutical research, particularly in developing new drugs targeting viral and bacterial …
3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H
B Wu, J Tang, DJ Wilson, AD Huber… - Journal of medicinal …, 2016 - ACS Publications
Resistance selection by human immunodeficiency virus (HIV) toward known drug regimens
necessitates the discovery of structurally novel antivirals with a distinct resistance profile. On …
necessitates the discovery of structurally novel antivirals with a distinct resistance profile. On …
Investigating the role of metal chelation in HIV-1 integrase strand transfer inhibitors
A Bacchi, M Carcelli, C Compari… - Journal of medicinal …, 2011 - ACS Publications
HIV-1 integrase (IN) has been validated as an attractive target for the treatment of HIV/AIDS.
Several studies have confirmed that the metal binding function is a crucial feature in many of …
Several studies have confirmed that the metal binding function is a crucial feature in many of …
3-Hydroxypyrimidine-2, 4-diones as an inhibitor scaffold of HIV integrase
J Tang, K Maddali, M Metifiot, YY Sham… - Journal of medicinal …, 2011 - ACS Publications
Integrase (IN) represents a clinically validated target for the development of antivirals
against human immunodeficiency virus (HIV). Inhibitors with a novel structure core are …
against human immunodeficiency virus (HIV). Inhibitors with a novel structure core are …